R--NHLBI Internal Communication Services
ID: 75N92024Q1125Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NHLBIBETHESDA, MD, 20892, USA

NAICS

Marketing Consulting Services (541613)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Original Source

https://sam.gov/opp/41fc55e17f244fd18d30a5268b340cac/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), is seeking information from qualified business sources for its Internal Communication Services requirement through a Sources Sought notice. This notice aims to gather insights on the availability and capabilities of potential vendors to assist in determining the appropriate acquisition method, including the possibility of a set-aside. The services sought are crucial for enhancing internal communication within the NHLBI, which plays a vital role in public health and research initiatives. Interested parties can reach out to Melanie Suarez at melanie.peel@nih.gov or call 301-435-0330 for further details, as this is not a solicitation for proposals at this stage.

    Point(s) of Contact
    Suarez, Melanie
    (301) 435-0330
    melanie.peel@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    R--NHLBI Internal Communication Services
    Currently viewing
    Sources Sought
    Similar Opportunities
    Health Information Management Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide Health Information Management Support Services at the NIH Clinical Center in Bethesda, Maryland. The procurement involves delivering comprehensive health information management services, including customer service, diagnostic and procedural coding, and transcription of medical reports, to enhance patient care and support clinical research. This contract is vital for maintaining high standards of health information management in a federally funded research hospital, ensuring compliance with federal regulations and quality assurance protocols. Interested vendors must submit their quotes by October 14, 2024, and can direct inquiries to Lu Chang at lu-chang.lu@nih.gov.
    66--Smart-Kage System
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information regarding the procurement of a Smart-Kage System. This opportunity is categorized as a Sources Sought notice, aimed at identifying potential vendors capable of providing this analytical laboratory instrument, which falls under the NAICS code 334516. The Smart-Kage System is crucial for laboratory applications, enhancing research capabilities within the NIH's National Heart, Lung, and Blood Institute (NHLBI). Interested parties are encouraged to reach out to Helmut Winffel at helmut.winffel@nih.gov or call 301-435-0330 for further details and to express their interest in this procurement opportunity.
    SOURCES SOUGHT: Maintenance and Repair Service for a 3730XL DNA Analyzer
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide maintenance and repair services for a 3730XL DNA Analyzer utilized by the National Institute on Aging (NIA). The procurement aims to ensure the continued functionality of this critical laboratory equipment, which supports neurogenetics research, through comprehensive maintenance support, including preventative maintenance, software upgrades, and timely troubleshooting. Interested vendors must submit a capability statement detailing their qualifications, including their business classification under the applicable NAICS code, by October 8, 2024, at 3:00 PM Eastern Time, to Rashiid Cummins at rashiid.cummins@nih.gov. The contract will span one base year from November 2024 to November 2025, with four optional extension years available.
    The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for the Liver Cirrhosis Network
    Active
    Health And Human Services, Department Of
    Special Notice HEALTH AND HUMAN SERVICES, DEPARTMENT OF seeks industry partners for clinical research collaborations on therapeutics, diagnostics or devices for the Liver Cirrhosis Network. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is looking for industry collaborators to provide novel or repurposed therapeutic agents, diagnostic markers, biomarkers, devices, or services for use in NIH-sponsored multi-center clinical trials and ancillary studies in adult patients with advanced liver disease and cirrhosis. The Liver Cirrhosis Network aims to promote clinical and translational research on cirrhosis of the liver and related complications in adults. The network is interested in conducting research that will lead to improved clinical outcomes in adults with cirrhosis and advanced liver disease. Commercial organizations interested in pursuing clinical collaborations with NIDDK for cirrhosis liver disease are required to submit a Capability Statement to the NIDDK.
    BULK LIQUID CARBON DIOXIDE (CO2) AND LIQUID NITROGEN (LN2) WITH TELEMETRY MONITORING (AMBIS 2240008)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of bulk liquid carbon dioxide (CO2) and liquid nitrogen (LN2) with telemetry monitoring under solicitation number RFQ-NIAID-25-2240008. The requirement includes approximately 193,000 pounds of beverage-grade liquid CO2 and 41,000 cubic centimeters of liquid nitrogen, along with a telemetry monitoring system to report tank levels and forecast delivery needs. These gases are essential for maintaining the integrity of samples stored in freezers at the NIH labs, highlighting their critical role in ongoing research activities. Interested vendors must submit their quotes by October 4, 2024, at 4:00 PM EST, and can direct inquiries to Rita Davis at rita.davis@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    BD Biosciences BD FACSLyric™ 3L10C Lease, Consumables and Service
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source Indefinite Delivery/Indefinite Quantity (IDIQ) contract to BD Biosciences for the lease of laboratory instruments, including the BD FACSLyric™ 3L10C Instrument and related consumables and services. This procurement is essential for maintaining the operational capabilities of the Clinical Center, as the proprietary reagents and instruments are critical for patient cell therapy protocols that comply with FDA regulations. The contract will cover a base year of twelve months with four additional one-year option periods, and interested parties capable of providing similar products or services are invited to submit capability statements by the specified deadline. For further inquiries, contact Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Center for Advancing Translational Sciences (NCATS), is seeking qualified small businesses to provide Chemistry, Manufacturing, and Controls (CMC) and related services for the development of drug products. The objective of this procurement is to support the Therapeutic Development Branch in ensuring the delivery of drug products of sufficient quality and quantity for preclinical, IND-enabling, and clinical studies, which are critical for advancing therapeutic candidates through the drug development pipeline. This opportunity is part of a Small Business Sources Sought notice, aimed at gathering information on the capabilities of small businesses to fulfill these requirements, with a focus on compliance with applicable regulations and the potential for a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract. Interested vendors must submit their capability statements by 10:00 AM Eastern Time on July 21, 2024, to Michelle Cecilia at michelle.cecilia@nih.gov.
    Qiagen LLC Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a firm fixed-price contract to Qiagen LLC for the procurement of reagent kits and consumables essential for isolating DNA and RNA from patients' blood samples. The reagents are critical for conducting tests related to hematological disorders and stem cell transplants, supporting both clinical care and research initiatives within the NIH's Department of Laboratory Medicine. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source procurement due to the unique capabilities of Qiagen LLC's products, which have been fully validated for specific assays. Interested vendors capable of providing similar products are encouraged to submit capability statements to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov by the specified deadline.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Sources Sought-Pipette Calibration Services
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking qualified contractors to provide pipette calibration services for its Clinical Center, with a focus on maintaining compliance with accreditation standards set by the College of American Pathologists and the Joint Commission. The selected contractor will be responsible for performing calibrations on up to 570 single-channel and 71 multi-channel pipettes twice annually, ensuring accuracy and reliability in clinical testing through adherence to ISO17025 and ISO08655 specifications. This procurement is critical for quality control in laboratory settings, directly impacting patient safety and the integrity of clinical results. Interested parties must submit their responses by email to Sheri Eiri at sheri.eiri@nih.gov by 12:00 pm Eastern Standard Time on October 6, 2024, noting that funding is currently not available for this project and that the estimated period of performance spans from November 1, 2024, to October 31, 2029, with options for extensions.